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 Our goal was to ascertain if DNA damage induced by oxidative stress is capable 
of being exploited as a precancerous or cancer biomarker. The specific DNA damage that we 
assessed was oxidatively induced non-DSB clustered DNA lesions (OCDLs). We further wanted 
to investigate if OCDL formation could be decreased by reducing reactive oxygen species (ROS) 
and oxidative stress. To accomplish this, we utilized the superoxide dismutase antioxidant, 
Tempol. Finally, we wanted to assess the role of specific cytokines and their part of inducing 
OCDLs in tissues both proximal and distal to a tumor mass. 
For our first experiment, lung carcinoma cells were injected into nude mice in 
collaboration with the National Cancer Institute. We evaluated the DNA damage in various tisue 
samples, distal and proximal to the tumor, and compared the level the damage to control B6 mice 
with normal immune system. To conclude if reducing ROS effects OCDL accumulation, a cohort 
of NUDE mice were fed the antioxidant Tempol. To establish the effects of a fully functioning 
immune system on OCDL formation, tumor cells were also injected into a cohort of normal B6 
mice. 
The second experiment was performed to evaluate the specific roles that cytokines and 
inflammation play in inducing OCDL damage in tissues from tumor bearing mice. A cytokine 
analysis was previously performed by Redon et al. which indicated in the presence of Sarcoma, 
  
monocyte chemoattractant protein-1 (MCP-1) was up regulated. To implement the specific role 
of MCP-1 in mediating the “bystander effect”, our experiment entailed MCP-1 being knocked 
out for a group of mice and assessing the amount of OCDL damage in various tissues.  
We utilized repair enzymes as probes to measure the level of OCDLs. These repair 
enzymes, human APE1, human OGG1, and E. coli Endo III, have functional activity in vivo. 
Once detection of a lesion in a cluster occurs, excision of the damaged base and of the DNA 
strand will transpire. Each DNA strand will now display a single stranded break which, if within 
1-10 base pairs, results into a double stranded break. These additional breaks are measured as 
clustered lesions and assessed via neutral agarose gel electrophoresis and calculated with number 
average length analysis (NALA). 
Earlier prognosis and detection of a growing tumor is a significant aspect of successful 
treatment. From these experiments, we hope to establish OCDLs as precancerous or cancer 
biomarkers in the case of high oxidative stress. It is hopeful one day clinical biopsies can be 
performed to screen for this specific damage and indicate early complications and tumor growth.        
Future experiments can be projected based on our study. Different tumors can be utilized 
to assess OCDL damage. An inclusion of wider variety of tissues will further establish the 
complex DNA damage induced by the bystander/distal effect with ROS and inflammation as 
mediators of this damage.   
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CHAPTER 1: INTRODUCTION 
In 2010, the projected second leading cause of death is cancer (CDC, 2010). This being 
so, it is imperative more knowledge about the disease and mechanisms be understood. With 
further investment, earlier detection can be achieved, ultimately leading to better prognosis. 
Damage to DNA occurs frequently and varies in type and complexity. It can range from 
simple single strand breaks, double strand breaks, and base damages to more complex closely 
spaced lesions i.e. clustered DNA damage (FIGURE 1). All these damages are characteristically 
repaired via conventional repair mechanisms for instance through base excision repair (BER) 
(FIGURE 2), nucleotide excision repair (NER), and double stranded break (DSB) repair. 
Inaccurate and insufficient repair of this impairment can often lead to mutations, genomic 
instability, transformation and formation of cancer. 
 Radiolytic attacks to DNA that lead to damage can be divided into two broad categories 
based on the source: endogenous and exogenous. Exogenous attacks arise from specific 
interaction to ionizing radiation such as X-,γ-, or cosmic rays. Endogenous attacks originate from 
natural occurrences inside the body for instance through cell signaling, metabolic processes and 
inflammation (Vilenchik and Knudson, 2003). During endogenous attacks, the primary source of 
damage to DNA is attributable to reactive oxygen species (ROS) and reactive nitrogen species 
(RNS). Formation of ROS/RNS occurs throughout the body. In the mitochondria, ROS is formed 
as a byproduct during oxidative phosphorylation. In macrophages and neutrophils, ROS is 
synthesized enzymatically. ROS has the capability to react with proteins, lipids, and DNA, 
leading to damage. Abasic sites, oxypyrimidines, oxypurines, single stranded breaks (SSB) and 
double stranded breaks (DSB) are the typical types of damage associated with ROS‟s interaction 
with DNA.  
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Improper repair and accumulation of the associated damages may lead to mutations, 
various pathophysiological conditions like “aging”, and potentially cancer. Based upon the 
complexity of the damage, different repair systems are implemented ultimately leading to 
different outcomes (FIGURE 3). Base Excision repair is a repair system that utilizes several 
different enzymes. OGG1 is an enzyme that recognizes oxypurines and hydrolytically cleaves 
and eradicates the damaged base via N-glycosylase activity. This creates an apurinic (AP) site. 
The AP-lyase activity creates an incision 3‟ to the sugar which has the missing base. Polymerase 
β inserts the missing base, followed by DNA ligase III sealing the gap (Georgakilas, 2008).  
Endonuclease III (ENDO III) is a glycosylase that acts in a similar fashion. ENDO III 
acts, upon other substrates, on oxypyrimidines. Upon recognition of the oxypyrimic site, N-
glycoslyase activity releases the damage pyrimidine. The AP-lyase activity cleaves the 
phosphdiester bond 3‟ to the AP site leaving a 5‟ phosphate and a 3‟ ring opened sugar (Gros, et 
al. 2002; Georgakilas, 2008). 
Human apurinic/apyrimidinic (AP) endonuclease (APE1) is a damage probe that cleaves 
the DNA backbone immediately 5‟ to the AP site, generating a single-strand break, leaving a 3‟ –
hydroxyl and 5‟ –deoxyribose phosphate terminus (Georgakilas, 2008). 
Simple DNA lesions utilize this repair and enzymes with superior efficiency. When the 
DNA damage is more complex, repair efficiency decreases. When two or more lesions occur 
within 1-10bp, the damage is said to be clustered. If these clusters are induced by oxidative 
sources, they are more properly known as oxidatively induced clustered DNA lesions (OCDL) 
(Sutherland et al. 2000). OCDLs have been demonstrated to create hindrances to normal efficient 
DNA repair processes. It was first introduced by Chaudry and Weinfeld that DNA lesions are 
repaired sequentially, meaning as the completion of repair to one lesion occurs, the initiation of 
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repair to the next takes place (Chaudry and Weinfeld, 1997). With clustered DNA lesions, it has 
been suggested that due to the close vicinity, DSBs can occur (Georgakilas, 2007).  
In vivo verification of OCDLs damage being repair resistant was seen from a study 
performed by Gollapalle et al. in 2007. Mice were exposed to exogenous radiation and displayed 
increased levels of OCDL damage 20 weeks after initial exposure. Interestingly, it was seen that 
distal tissues, which were protected from the radiation, too showed increased levels of OCDLs. 
The mechanisms behind this effect, known as the bystander/distal effect, are still not completely 
understood. Little et al, demonstrated that suppression of the bystander effect can be seen with 
the addition of a superoxide dismutase and inhibition of NADPH oxidase, indicating oxidative 
stress as the mediator to this effect (Little and Azzam, 2002). Further studies have implicated this 
effect to be arbitrated by several factors associated with oxidative stress, including inflammation, 
cytokines, and cellular signaling (Redon et al. 2010). To attempt to address which cytokine(s) 
may play a role in the bystander/distal effect in vivo, Redon et al. performed a cytokine analysis. 
One cytokine found in elevated levels in sarcoma bearing mice was the monocyte 
chemoattractant protein 1 (MCP-1) also known as chemokine (C-C) ligand 2 (CCL-2).  
Inflammation is an essential mechanism in our body during immune responses. Cells of 
the immune system, such as macrophages and neutrophils, function by releasing chemicals or 
cytokines that disrupt foreign membranes, increase opsonization, provide chemotaxis, and 
elevate inflammation (Sebald and Nikel, 2009). The cytokine monocyte chemoattractant protein-
1 (MCP-1) was first illustrated to function as a necessary signal for recruitment of monocytes to 
a site of injury where differentiation can occur to macrophages. Since, MCP-1 has been 
implicated as a source for numerous inflammatory diseases (Brewald et al, 2007; Dewald et al, 
2005; Popivanova et al, 2009). MCP-1 also functions as a stimulant to the production of 
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transforming growth factor β (TGF-β). TGF-β is a protein that is normally found in the body that 
regulates cell growth by inhibition. Cancerous cell‟s TGF-β pathway display mutations and was 
seen, when added to cell cultures at increased levels, induced DNA lesions (Sokolov et al, 2005; 
Sedelnikova et al, 2007; Prise and O‟Sullivan, 2009). 
To attempt to utilize OCDLs and phosphorylated histone H2AX as cancer biomarkers, 
especially in the case of oxidative-stress related cancers, Redon et al designed a study comparing 
the frequency of the associated damage in different tissues in tumor bearing mice. The tissue 
samples were as follows: duodenum, colon, rectum, stomach, liver, kidney, lungs, ovary, skin, 
bone marrow, and spleen. The associated tumor was melanoma or adenocarcinoma. Redon et al 
examined levels of phosphorylated histone H2AX (γ-H2AX), which indicates the presence of 
DSBs (a form of clustered DNA lesions). DNA lesions were indeed shown at elevated levels. 
Tissues that replicate frequently displayed further elevation of DSBs and OCDLs and greater 
sensitivity to the bystander/distal effect.   
To further this study, we modified the protocol and executed an additional set of 
experiments. For the first experiment, we had six sets of mice, six mice per set, and six different 
cohorts. Six mice were PBS sham controls. To address the role of inflammation with respect to 
OCDL formation, six mice were fed with Freund‟s adjuvant as an inflammation control. To 
identify the potential increase in oxidative damage in association with the presence of tumors, six 
nude mice were injected subcutaneously with lung carcinoma cells. Six lung carcinoma bearing 
nude mice were fed the antioxidant Tempol (FIGURE 4) to elucidate the effects of antioxidants 
in the presence of tumors. A corresponding set of mice were fed Tempol to identify a base level 
as a control. To test the possible role of the immune system in the accumulation of OCDLs, a 
final set of six B6 lung carcinoma bearing normal mice were added. We hypothesized a growing 
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lung carcinoma tumor will induce a higher amount of OCDLs than in control mice tissues 
(distant and proximal to the tumor). Also, with the presence of lung carcinoma, the tissues that 
are most proximal to the carcinoma will display the highest amounts of OCDLs compare to 
distant. 
Tempol, 4-hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl, is a nitroxyl radical, with 
membrane permeable properties. It acts as a superoxide dismutase mimetic that seeks and 
neutralizes superoxide anions (Chatterjee, 2000). 
In order to assist with the determination if the absence of MCP-1 abrogates DNA damage 
in tumor bearing mice, a second experiment was performed. Two different groups were 
established, four sets, five mice per set per group. The first group, MCP-1 was knocked out. One 
set of mice were injected subcutaneously with sarcoma cells. A second set of mice were injected 
subcutaneously with melanoma cells. To maintain a background level of oxidative damage, a 
control of five mice were utilized. To establish again an inflammation control, five mice were 
fed Freund‟s adjuvant. Two tissues were analyzed: duodenum and colon.  
The second group for this experiment maintained the same cohorts, but utilized normal 
B6 mice as opposed to MCP-1 ko. We hypothesized the mechanism involved in OCDL induction 
in tumor bearing mice involves MCP-1 cytokine and use of antioxidant tempol will reduce the 
OCDL levels, verifying the presence of high oxidative stress in animals. 
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Figure 1: Simple vs. Complex DNA Damage 
 
Figure 1: Simple DNA damage is illustrated above. Single lesions exhibit exceptional 
proficiency in repair. Clustered DNA damage is defined as two or more damaged bases or 
lesions present in opposing strands within 1 to 10 base pairs. Clustered DNA lesions have been 
demonstrated to be repair resistant. Light squares denote undamaged bases. Damage to 
individual nucleotides comprise missing or damaged (red squares) bases and strand breaks 
(accompanied by base loss).      
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Figure 2: Base Excision Repair Pathway 
 
Figure 2: Several enzymes are utilized during base excision repair (BER). Specific enzymes can 
recognize and hydrolytically cleave and eliminate the impaired base, creating an 
apurinic/apyrimidinic (AP) site. This AP site is acted on APE1 which creates an incision 5` to 
the sugar which was missing the base. DNA polymerase β inserts the missing base, followed by 
the patching of the single nucleotide gap. The final player is DNA ligase III and XRCC1 
complex which seals the gap.       
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Figure 3: ROS Effects on DNA 
CANCER
CELL
(A) A Normal Cell is 
damaged from an 
exogenous source
(B) Potential effects of ROS on DNA.
 
Figure 3: Potential formation of ROS. In 3A, a mutation is introduced by an exogenous source. 
Figure 3B exemplifies the outcome of the newly created ROS and its interaction with DNA. 
Three outcomes from this interaction are displayed. In one scenario, the DNA will utilize 
sequential repair through the use of the primary repair systems NER and BER. The DNA is then 
repaired successfully. The second scenario is shown where no repair occurs leading to DSB and 
ultimately cell death. The final scenario depicts mutations generated from the improper repair. 
Cells with the mutations replicate, potentially leading to the creation of cancer cells.   
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Figure 4: Structure of Tempol  
 
 
 
Figure 4: Antioxidant utilized in the Lung Carcinoma Experiment. 4-hydroxy-2,2,6,6-
tetramethylpiperidine-1-oxyl. Tempol characteristics are: Water soluble, low MW, permeates 
biological membranes, scavenges superoxide anions in vitro, superoxide dismutase mimetic, 
reduces intracellular concentration of Fe
2
+, and hence the formation of hydroxyl radicals via 
Fenton or Haber- Weiss reaction, short half life, and can switch between oxidized/reduced forms. 
 
 
 
 
 
 
  
CHAPTER 2: OBJECTIVES 
The first experiment determined the effects lung carcinoma has on the formation of 
OCDLs in different organs. Six sets, six mice per set were utilized. The first set of six mice were 
normal control. A second set of mice were injected with Freund‟s adjuvant. This adjuvant 
stimulated inflammation, allowing us to determine the role of basal inflammation plays in 
damage associated with an increase in oxidative stress. It is hypothesized inflammation is a 
contributable factor in the bystander effect. This adjuvant allowed us to assess the DNA damage 
with regards to this effect. A third set of six mice were nude mice injected with lung carcinoma 
cells. Nude mice lack a thymus. Without the thymus, no T-cell mediated immune response can 
occur. With implementing nude mice in the experiment, we could determine the level of DNA 
damage from specific sources. We compared the number of OCDLs in tissue DNA samples from 
these tumor bearing mice to the inflammation control mice. A set of nude lung carcinoma 
bearing mice were fed the antioxidant Tempol. By doing so, determination of the inhibition of 
ROS decreasing OCDL accumulation was made. A corresponding set of control plus the 
antioxidant Tempol was utilized for this comparison. A set of B6 normal mice were induced with 
lung carcinoma to determine the effect(s) of the immune system. The organs that were assessed 
were: Ovary, Lung, Spleen, Duodenum, Stomach, Colon, Rectum, Skin Distal to tumor, Skin 
Cervical to tumor, and Tumor Mass.  
A second experiment was performed to investigate the role of MCP-1 in the induction of 
OCDL damage. To execute this experiment, the gene encoding MCP-1 was knocked out. Four 
sets, five mice per set were utilized. One set of mice were the MCP-1 knocked out (ko) control. 
A set of mice were injected with Freund‟s adjuvant for an inflammation control. A third set of 
MCP-1 ko mice were inject with sarcoma cells. A final set of MCP-1 ko mice were injected with 
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melanoma cells. The duodenum and colon were the tissues analyzed for OCDL damage. To 
establish the effects sarcoma and melanoma obtain, the experiment was replicated using normal 
B6 mice. 
To compare the levels of OCDL damage, three repair enzyme probes were utilized: 
APE1, OGG1, and EndoIII. These enzymes function, in vitro, by detecting damaged DNA 
damage (TABLE 1). As a lesion is detected, the enzyme excises the damaged base and cleaves 
the DNA strand. From this, a single stranded break in each strand ensues. This in turn forms a 
double strand break, when within 0-20 bp, which is measured through an adaptation of non-
denaturing agarose gel electrophoresis and number average length analysis (NALA). 
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Table 1: Repair Enzymes  
Repair enzyme used as damage probe Substrates 
 Human APE1 or E. coli Nfo protein 
(Endonuclease IV)  
Abasic: Several types of abasic sites including 
oxidized abasic sites, abasic sites modified with 
alkoxyamines and DNA containing urea 
residues. 
 Human OGG1 or E.coli Fpg protein (DNA 
glycosylase) 
Associated AP lyase activity 
Oxypurines: Oxidized purines, FapyGua, 
FapyAde, C8-oxoGuanine, some abasic sites, 
C8-oxoAdenine and to a lesser extent, other 
modified purines. 
Human NTH1 protein or E.coli EndoIII 
(Endonuclease III) 
Associated AP lyase activity 
Oxypyrimidines: Thymine residues damaged by 
ring saturation, fragmentation, or ring 
contraction including thymine glycol (Tg) and 
uracil residues (5-fo-Ura), FapyAde, 5-OH-Cyt 
and to a lesser extent FapyGua. 
 
Table 1: Repair enzymes that were utilized in our experiments and their corresponding DNA 
damage substrates. 
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Figure 5: Overview of Lung Carcinoma Experiment 
Inflammation Control 
(Freunds Adjuvant)
Negative Control
(PBS)
Control + Tempol
Lung Carcinoma + 
Tempol (NUDE)
Lung Carcinoma 
(NUDE)
Lung Carcinoma (B6)
TISSUES
Ovary
Lung
Spleen
Duodenum
Stomach
Colon
Rectum
Skin Distal
Skin Cervical
Tumor Mass
 
 
Figure 5: This is a schematic of the Lung Carcinoma experiment, showing the different sets of 
treatment. Five sets of nude mice were utilized: normal control with no treatment, inflammation 
control injected with Freund‟s adjuvant, antioxidant treated control, lung carcinoma bearing, and 
lung carcinoma bearing fed the antioxidant Tempol.  A set of B6 mice were also injected with 
lung carcinoma cells to determine the effect of the normal immune system on OCDL damage. 
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Figure 6: Overview of MCP-1 ko and B6 Experiment 
TISSUES
Duodenum
Colon
MCP-1 ko / B6
(No Treatment) 
MCP-1 ko / B6
(Freund’s Adjuvant) 
MCP-1 ko / B6
(MO5076 sarcoma
-implanted)
MCP-1 ko / B6
(B16 melanoma
-implanted)
 
Figure 6: This is a schematic of the MCP-1 ko and B6 (normal immune). Two groups were 
utilized. The first group had the gene encoding MCP-1 knocked out. There was four sets, each 
set containing five MCP-1 ko. The first set of MCP-1 ko mice were normal control with no 
treatment. Second, an inflammation control injected with Freund‟s Adjuvant. Two tumors were 
tested: sarcoma and melanoma. The same format was followed but with normal B6 mice. This 
provided a control to the MCP-1 ko experiments. 
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Figure 7: Agarose gel showing Clustered DNA Damage (Example) 
 
 
Figure 7: From left - 
Lane 1:  DNA λ-HIND III digest (utilized as marker) 
Lane 2: DNA No enzyme 
Lane 3: DNA Enzyme treated 
Lane 4: DNA No enzyme 
Lane 5: DNA Enzyme treated 
 
 
 
 
Clustered DNA Lesions 
{     } 
  
CHAPTER 3: HYPOTHESIS 
We have three hypotheses: 
1. Growing lung carcinoma will induce a higher amount of OCDLs in tumor bearing mice 
compared to normal mice tissue (distant and proximal to the tumor). 
2. With the presence of lung carcinoma, the tissues that are most proximal to the carcinoma will 
display the highest amounts of OCDLs compared to distant.  
3. The mechanism involved in OCDL induction in tumor bearing mice involces MCP-1 cytokine 
and use of antioxidant Tempol will reduce the OCDL levels, verifying the presence of high 
oxidative stress in animals. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
CHAPTER 4: METHODS 
Tissue Source 
The mouse DNA samples were a gift from Dr. Sedelnikova and Dr. Bonner from Center 
for Cancer Research, NIH. The lung carcinoma experiment utilized expansively characterized, 
MAP tested, and cryoarchived samples of mouse Lewis (NSC-224131) lung carcinoma (host 
strain C57BL/6). These were obtained from the DCTD tumor repository at NCI-Frederick. The 
lung carcinoma was first passaged through "donor” mice. After, it was implanted into 6 test nude 
mice; 6 mice were subjected to a single subcutaneous injection of complete Freund's adjuvant, 
and other 6 mice served as a sham control. After two weeks, all animals were sacrificed followed 
by DNA damage assessment on various tissues. 
To investigate the mechanisms of the bystander/distal effect and associated DNA damage 
from possible elevation of oxidative stress from the presence of a tumor, an additional cohort 
was introduced. Six tumor-bearing mice were fed Tempol, an antioxidant. A corresponding 
control group of mice were fed Tempol with no tumor treatment. Both cohorts followed the 
protocol as described above. The antioxidant Tempol was obtained from Dr. James Mitchell, 
Radiation Biology, NCI. The Tempol was administered as 10 mg Tempol/gram of chow. To 
adjust accordingly for the diet, mice were fed the antioxidant two weeks prior to the experiment 
and continued the two weeks of the experiment. Body weights were taken at the feeding start 
point, the first day of experiment, and at the time of sacrifice.  
To examine the role of cytokines in mitigating the increase in oxidative damage, ten B6 
and ten MCP-1 ko normal mice were implanted with melanoma and sarcoma cells. The 
procedures were replicated as described above. 
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Isolation of DNA 
The “High Pure PCR Template Kit” (Roche, Indianapolis, IN) was utilized for isolating 
DNA from the mouse tissues. As stated from the manufacturer, DNA fragments yielded ranged 
from six to 28kbp. Tissues were stored at -20°C until isolation was performed. Once removed, 
tissues were kept on ice. Samples were incised into smaller fragments to improve nucleic acid 
amount yielded. 25-50mg of tissue sample was obtained. In a nuclease-free 1.5 mL micro 
centrifuge tube, 200µl of tissue lysis buffer (4M urea, 200mM Tris, 20mM NaCl, 200mM 
EDTA, pH 7.4) was added followed by 40µl of reconstituted Proteinase K. Proteinase K was 
added to assist with the inactivation and degradation of endogenous DNase and sample lysis. The 
sample was mixed immediately and placed in an incubator for 12 hours at 37°C. Once 12 hours 
were complete, 200µl of binding buffer was added followed by being vortexed. The sample was 
then placed in an incubator for 10 minutes at 65°C. After 10 minutes, 100µl of isopropanol 
alcohol was added and vortexed. Any insoluble tissue segments were removed using a 1000µl 
sterile pipette tip. The sample material that remained in the microcentrifuge tube was then 
transferred into a High Filter tube located inside a Collection tube. 500µl of Inhibitor Removal 
Buffer (5M guanindine-HCl, 20mM Tris-HCl, 37.7% absolute ethanol (v/v), pH 6.6) was added. 
The microcentrifuge tube and Collection tube was then placed in a centrifuge and spun for one 
minute at 8,000g. The Collection tube was then discarded. The High Filter tube, containing the 
sample, was removed and placed into a new Collection tube. 500µl of wash buffer (80% absolute 
ethanol (v/v), 20mM NaCl, 2mM Tris-HCl, pH 7.5) was added to the High Filter tube and spun 
down at 8,000g for one minute. The wash was repeated twice. The Collection tube was discarded 
and the High Filter tube was placed in a new, sterile collection tube. The tubes were again placed 
in a centrifuge and were spun down at 14,000g for 15 seconds. To elute the DNA, the High Filter 
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tube was placed into a sterile 1.5 mL microcentrifuge tube. 200µl of pre-warmed (65°C) Elution 
Buffer (10mM Tris-HCl, pH 8.5) was added to the assembly and centrifuged for 75 seconds at 
8,000g. Upon completion, the 1.5 mL microcentrifuge tube contained the isolated DNA from the 
sample. 
 
Measurement of DNA concentration 
1µl of the DNA sample was analyzed using a nanodrop spectrophotometer. This 
calculated the amount of sample required for analysis of the DNA. The Absorbance readings 
were read at 260nm and 280nm automatically. To blank the nanodrop, 1µl of TE buffer (10mM 
Tris-HCl, 1mM EDTA, pH 7.5) was utilized as a control. The purity and concentration of the 
DNA sample was derived from these values. 
 
Detection and measurement of oxidative clustered DNA lesions 
To detect the OCDL levels (FIGURE 8), constant gel electrophoresis along with 
quantitative analysis and number average length analysis (NALA) was performed. 
Microcentrifuges tubes were utilized to contain the sample during analysis. 1 μl of DNA was 
added with 6.5 μl of the appropriate enzyme buffer was added into the microcentrifuge tube and 
left on ice. The buffers utilized were: APE1 buffer (50mM potassium acetate, 20mM Tris 
acetate, 10mM magnesium acetate, pH 7.9), OGG1 buffer (50mM NaCL, 10mM MgCl2, 10mM 
Tris-HCl, pH 7.9), and EndoIII buffer ( 20mM Tris-HCl, 1mM EDTA, pH 8.0). Each sample 
was analyzed with no enzyme (negative) followed by with enzyme addition (positive). The repair 
enzymes APE1, OGG1, and ENDO III were used as the enzymatic probes and hydrolytically 
cleaved the DNA at their specific oxidative damaged site as summarized in (Table 1). Next was 
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the addition of 1µl of dithiothreitol (DTT, 10mM; Sigma).  Samples were left to incubate for five 
minutes on ice. For the positive set, 1 µl of the appropriate was added (1 unit for hAPE1 and 
EndoIII, 0.2 units for hOGG1), followed by five seconds of vortexing. Samples were then 
transferred to 37
o
C water bath and incubated for 65 minutes. After incubation, 5µl of ice cold 
Native Stop Solution (NSS) was added. The samples were then placed on ice for 60 minutes. 
After 60 minutes, samples were loaded onto gels (85% agarose (w/v); Biorad) and placed into 
the chamber filled with 0.25X TBE (22.25mM Tris-borate, 0.5mM EDTA) and left for 10 
minutes to equilibrate. After equilibration, constant gel electrophoresis was performed and ran 
for three hours and 40 minutes at 50 V. Gels were then stained with Ethidium Bromide (1 ng/µl) 
and left overnight for de-staining. λ-HIND III digest (Fisher) was utilized as the DNA standard 
and also run on the gel. Preparation consisted of the addition of 5µl of TE buffer, 5µl of NSS, 
and 0.75µl of marker. It was then placed in 65
o
C for three minutes and left on ice until the gel 
was ready for loading. 
 Electronic gel images were obtained through FluorChem 8900 imaging system and 
AlphaEase FC software (Alpha Innotech, San Leandro, CA). Samples were processed using 
Quantiscan software (Biosoft, Ferguson, MO) and a densitogram was obtained (FIGURE 9). The 
program Origin 6.1 (Origin Lab, Northampton, MA) was utilized to plot a dispersion curve 
(FIGURE 10) using the marker which acted as the DNA standard contained bands between two 
and 23.1kbp.  
The frequency of various clusters were obtained using the contour length of DNA 
molecules migrating to a certain position and the fluorescence profile of a lane, which was 
outlined in the procedure by Sutherland et al (Sutherland, Bennett et al. 2003). 
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If a population of Nu duplex DNA molecules in which the i
th
 molecule contains Li base 
pairs, the average length of the molecules in the population can be expressed by Equation {1}.  
U
N
i
U
N
Li
L
  1
      {1} 
The sum in the numerator on the right side of Equation {1} is the number of base pairs present in 
the sample. The subscript “U” indicates that the sample is untreated. When a sample is treated 
with an enzyme, it introduces M double strand breaks in the Nu molecules in the population. 
These breaks could be randomly distributed, be produced at specific sites in the molecules, or 
have many other distributions. Regardless of the distribution, each strand breaks result in the 
formation of two smaller molecules. Consequently, the number of molecules in the population 
treated NT can be represented by Nu + M molecules. The average length of the molecules in this 
population is shown in Equation {2} where “T” denotes a treated sample.  
MN
Li
L
U
MNu
i
T




1
         {2} 
With the formation of a single strand break, the number of molecules increases but the number of 
base pairs does not. Because of this, the sum in the numerators of Equation {1} and {2} are the 
same. Both can be substituted with Nbp, the number of base pairs in the population. Upon 
rearrangement of the equation NT=NU + M we obtain M=NT-NU. Dividing by Nbp we can get the 
frequency of the breaks (Ф). This is shown in Equation {3}. 
bp
U
bp
T
bp N
N
N
N
N
M

     {3} 
When we replace Nbp for the sums in Equations {1} and {2}, we obtain: 
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. 
When we swap these expressions into Equation {3}, we get the expression for frequency as 
shown in Equation {4}. 
uT LL
11

      {4} 
For molecules whose lengths are measured in base pairs, the (Ф) is the probability of a strand 
break per base pair. Thus (Ф) is the frequency of breaks induced by the treatment, and is 
determined in units such as breaks/Gbp by measurement of average length of molecules in a 
population before and after enzyme treatment. Since both the numerator and denominator of 
Equations {1} and {2} scale as the mass of DNA, not all of the molecules in that population need 
to be measured, but only a representative sample. The determination of average lengths is 
insensitive to the mass of sample chosen, as long as it is low enough so that individual molecules 
migrate as a function of their length (Sutherland et al. 2003).      
 
A outline view of the procedure: 
1. DNA isolated from tissue 
2. Treated or not treated with repair enzyme 
3. Constant field agarose gel elctrophoresis performed 
4. Gel stained with Ethidium Bromide 
5. Image obtained using FluoroChem 890 imaging system from Alpha Innotech. 
6. Intensity profiles generated by Quantiscan software 
7. Dispersion curve (size vs migration) prepared by using Origin 6.0 for the marker 
fragments.  
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a. Second order exponential fit yields equation with parameters (y0,a1,t1,a2,t2) 
8. The contour length of the DNA molecules migrating to a certain position and the 
fluorescence profile of a lane is used to calculate the frequency of OCDLs. 
a. Area calculated using trapezoid rule 
b. Half point of migration (xmed) is found 
c. The standard curve and parameters from the marker fragments is utilized to 
convert the point of half migration (xmed) to the median length in bases (Lmed) 
d. The median length in bases (Lmed) is converted to average molecular length 
(Ln)using the equation Ln =0.6 Lmed 
e. Determine number of clusters (Ф) using the equation: Ф=1/LT-1/LU  
i. Where, LT= average molecular length of treated sample 
ii. LU=average molecular length of untreated sample 
iii. Ф=number of clusters (bp) 
(Sutherland et al. 2003). 
       f. Statistical analysis was performed using the student paired T-test; p<0.05.     
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Figure 8: Clustered DNA Damage Detection Using Repair Enzymes as Damage Probes 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8: Detection of clustered DNA lesions (double strand breaks, DSBs and oxidative clustered DNA 
lesions, OCDL). Figure 8A illustrates the means of detection using repair enzymes for a cluster 
containing a set bistranded base lesions as originally introduced by Sutherland, 2000. In one case, one of 
the lesions is a single strand break, SSB. With efficient repair and no cleavage of both strands at the site 
of the lesion, no detection of the cluster was seen. In scenario II, cleavage of both lesions by the enzyme 
induced a double strand break, DSB. The DSB provided detection of the cluster. Figure 8B displays 
detection of clusters using neutral agarose gel electrophoresis. DNA is subjected to agarose gel 
electrophoresis. With utilization of number average length analysis (NALA), the DSBs and OCDL were 
determined. A comparison is seen in the lanes with the enzyme and with the enzyme plus radiation. For 
lanes 1,2 (non-irradiated) low levels of endogenous OCDL are seen. For lanes 3,4 (irradiated) higher 
levels of OCDL are displayed. This is due to an increase in exogenous attacks from the radiation. 
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Comparison of lanes 3 and 1 provide the yield of DSBs. The same principle was utilized for the Lung 
Carcinoma and MCP-1 ko / B6 experiments to check for additional DSB formation upon treatment with 
the enzyme allowing us to quantify the clusters that are present.     
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Figure 9: Quantiscan Intensity Profile 
 
 
Figure 9: The figure displays a screen shot from Quantiscan. The intensity profile of a tumor 
bearing mouse sample with no enzyme treatment for the lung carcinoma experiment. The net 
area in circled. This corresponds to the intensity profile. 
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Figure 10: Origin Dispersion Curve 
 
 
Figure 10: A corresponding size (kbp) vs Migration dispersion curve for the DNA marker, DNA 
λ–Hind III is illustrated above. Fragment size (kbp) corresponds to the y axis, and migration 
values correspond to the x axis. Plot was made using Origin Lab 6.0.  
 
 
 
 
 
Migration 
Size (kbp) 
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Figure 11: MS Excel Cluster Input 
 
Figure 11: Upon determination of the net area, the value is entered in the data entry sheet. The 
area and migration coordinates that fall above and below the net area/2 are entered as well.  The 
equation Ln=0.6 Lmed was utilized. 
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Figure 12: Ms Excel Area Calculation 
 
Figure 12: The precise xmed center from the intensity profile in quantiscan is calculated to 6 
decimal places. 
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Figure 13: Ms Excel Cluster Calculation (Output) 
 
Figure 13: Equation {4} from Sutherland et al, yields the number of clusters  
(Column L : Row 4). The parameters obtained using Origin 6.0 are entered in the cells labeled in 
red. Cluster values are provided in Gbp. Determine number of clusters (Ф) using the equation: 
Ф=1/LT-1/LU; Example (Lane 4 – Lane 5). 
 
 
 
 
 
 
 
 
  
CHAPTER 5: RESULTS 
 The data that was obtained from the lung carcinoma experiment are shown in figures 13-
23. Figures 24-26 exhibit a cumulative analysis per enzyme treatment of the tissues that were 
utilized for the lung carcinoma experiment. To determine the existence of significant differences 
between different cohorts and groups of mice, A t test was executed at a significance level of 
p<0.05. The different comparisons were as follows: nude mice with lung carcinoma (TST) vs. 
inflammation control; nude mice TST vs. nude mice TST + Tempol; nude mice TST vs. B6 TST 
mice. The OCDL experiments were carried out a minimum of three repetitions per enzyme per 
sample.  In general, a trend is seen with an increase in cluster accumulation for the mice bearing 
lung carcinoma compared to the inflammation control and the PBS control. This increase of 
clusters is also seen to significantly decrease with the presence of the antioxidant Tempol. 
Proximity to the tumor shows no significant difference in cluster formation. This implies that the 
bystander effect is indeed being carried out. The damage detected in B6 mice bearing lung 
carcinoma vs. nude mice with lung carcinoma varied. This implies that a fully functioning 
immune system will not completely eradicate the damage associated from endogenous sources.   
 The data obtained from the MCP-1 ko and B6 experiments are shown in figures 27-30. 
Figures 31-33 exhibit a cumulative analysis per enzyme treatment of the tissues that were 
utilized for the MCP-1 ko and B6 experiment. Four statistical t-tests were performed at 
significance level of p<0.05 to examine the differences between the different cohorts and 
samples. They are as follows: MCP-1 ko inflammation control vs. MCP-1 ko TST (Melanoma); 
MCP-1 ko inflammation control vs. MCP-1 ko TST (Sarcoma); MCP-1 ko TST (Melanoma) vs. 
B6 TST (Melanoma); and MCP-1 ko TST (Sarcoma) vs. B6 TST (Sarcoma). The OCDL 
experiment was carried out a minimum of three repetitions per enzyme per sample. In general it 
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was seen that when MCP-1 was knocked out, there is a decrease in cluster damage. This 
implements the role of MCP-1 as a key component to cluster damage which corresponds to the 
findings performed by Redon et al (Redon et al, 2010). When compared to B6 mice bearing the 
different tumors, MCP-1 ko tumor bearing mice exhibit a general decrease in damage.  
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Figure 14: Cluster Analysis in Ovary Tissues - Lung Carcinoma Experiment 
 
 
 
 
** 
 * 
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Figure 14: Cluster damage detected in ovary tissue samples from lung carcinoma experiment for 
the three different enzymes that were utilized. The Y axis corresponds to the number of clusters 
(Gbp) and the X axis corresponds to the three different enzymes. Significant cluster 
accumulation between nude mice TST and inflammation control mice at p<0.05 is denoted by *. 
Significant difference between nude mice TST and nude mice TST + Tempol is denoted by **. 
Significant difference between nude mice TST and B6 TST mice is denoted by ***. 
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Figure 15: Cluster Analysis in Lung Tissues - Lung Carcinoma Experiment 
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Figure 15: Cluster damage detected in lung tissue samples from Lung Carcinoma experiment for 
the three different enzymes that were utilized. The Y axis corresponds to the number of clusters 
(Gbp) and the X axis corresponds to the three different enzymes. Significant cluster 
accumulation between nude mice TST and inflammation control mice at p<0.05 is denoted by *. 
Significant difference between nude mice TST and nude mice TST + Tempol is denoted by **. 
Significant difference between nude mice TST and B6 TST mice is denoted by ***. 
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Figure 16: Cluster Analysis in Spleen Tissues - Lung Carcinoma Experiment  
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Figure 16: Cluster damage detected in spleen tissue samples from Lung Carcinoma experiment 
for the three different enzymes that were utilized. The Y axis corresponds to the number of 
clusters (Gbp) and the X axis corresponds to the three different enzymes. Significant cluster 
accumulation between nude mice TST and inflammation control mice at p<0.05 is denoted by *. 
Significant difference between nude mice TST and nude mice TST + Tempol is denoted by **. 
Significant difference between nude mice TST and B6 TST mice is denoted by ***. 
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Figure 17: Cluster Analysis in Duodenum Tissues - Lung Carcinoma Experiment  
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Figure 17: Cluster damage detected in duodenum tissue samples from Lung Carcinoma 
experiment for the three different enzymes that were utilized. The Y axis corresponds to the 
number of clusters (Gbp) and the X axis corresponds to the three different enzymes. Significant 
cluster accumulation between nude mice TST and inflammation control mice at p<0.05 is 
denoted by *. Significant difference between nude mice TST and nude mice TST + Tempol is 
denoted by **. Significant difference between nude mice TST and B6 TST mice is denoted by 
***. 
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Figure 18: Cluster Analysis in Stomach Tissues - Lung Carcinoma Experiment  
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Figure 18: Cluster damage detected in stomach tissue samples from Lung Carcinoma 
experiment for the three different enzymes that were utilized. The Y axis corresponds to the 
number of clusters (Gbp) and the X axis corresponds to the three different enzymes. Significant 
cluster accumulation between nude mice TST and inflammation control mice at p<0.05 is 
denoted by *. Significant difference between nude mice TST and nude mice TST + Tempol is 
denoted by **. Significant difference between nude mice TST and B6 TST mice is denoted by 
***. 
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Figure 19: Cluster Analysis in Colon Tissues - Lung Carcinoma Experiment  
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Figure 19: Cluster damage detected in colon tissue samples from Lung Carcinoma experiment 
for the three different enzymes that were utilized. The Y axis corresponds to the number of 
clusters (Gbp) and the X axis corresponds to the three different enzymes. Significant cluster 
accumulation between nude mice TST and inflammation control mice at p<0.05 is denoted by *. 
Significant difference between nude mice TST and nude mice TST + Tempol is denoted by **. 
Significant difference between nude mice TST and B6 TST mice is denoted by ***. 
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Figure 20: Cluster Analysis in Rectum Tissues - Lung Carcinoma Experiment  
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Figure 20: Cluster damage detected in rectum tissue samples from Lung Carcinoma experiment 
for the three different enzymes that were utilized. The Y axis corresponds to the number of 
clusters (Gbp) and the X axis corresponds to the three different enzymes. Significant cluster 
accumulation between nude mice TST and inflammation control mice at p<0.05 is denoted by *. 
Significant difference between nude mice TST and nude mice TST + Tempol is denoted by **. 
Significant difference between nude mice TST and B6 TST mice is denoted by ***. 
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Figure 21: Cluster Analysis in Skin (Lateral) Tissues - Lung Carcinoma Experiment  
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Figure 21: Cluster damage detected in skin (lateral) tissue samples from Lung Carcinoma 
experiment for the three different enzymes that were utilized. The Y axis corresponds to the 
number of clusters (Gbp) and the X axis corresponds to the three different enzymes. Significant 
cluster accumulation between nude mice TST and inflammation control mice at p<0.05 is 
denoted by *. Significant difference between nude mice TST and nude mice TST + Tempol is 
denoted by **. Significant difference between nude mice TST and B6 TST mice is denoted by 
***. 
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Figure 22: Cluster Analysis in Skin (Cervical) Tissues - Lung Carcinoma Experiment  
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Figure 22: Cluster damage detected in skin (cervical) tissue samples from Lung Carcinoma 
experiment for the three different enzymes that were utilized. The Y axis corresponds to the 
number of clusters (Gbp) and the X axis corresponds to the three different enzymes. Significant 
cluster accumulation between nude mice TST and inflammation control mice at p<0.05 is 
denoted by *. Significant difference between nude mice TST and nude mice TST + Tempol is 
denoted by **. Significant difference between nude mice TST and B6 TST mice is denoted by 
***. 
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Figure 23: Cluster Analysis in Skin (Tumor mass) Tissues - Lung Carcinoma Experiment  
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Figure 23: Cluster damage detected in skin (tumor mass) tissue samples from Lung Carcinoma 
experiment for the three different enzymes that were utilized. The Y axis corresponds to the 
number of clusters (Gbp) and the X axis corresponds to the three different enzymes. Significant 
cluster accumulation between nude mice TST and inflammation control mice at p<0.05 is 
denoted by *. Significant difference between nude mice TST and nude mice TST + Tempol is 
denoted by **. Significant difference between nude mice TST and B6 TST mice is denoted by 
***. 
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Figure 24: Abasic Cluster Analysis - Lung Carcinoma Experiment 
 
 
 
          
54 
 
 
Figure 24: Abasic clusters that were detected from the Lung Carcinoma Experiment. Significant 
cluster accumulation between nude mice TST and inflammation control mice at p<0.05 is 
denoted by *. Significant difference between nude mice TST and nude mice TST + Tempol is 
denoted by **. Significant difference between nude mice TST and B6 TST mice is denoted by 
***. 
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Figure 25: Oxypyrimidinic Cluster Analysis - Lung Carcinoma Experiment 
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Figure 25: Oxypyrimidinic clusters that were detected from the Lung Carcinoma Experiment. 
Significant cluster accumulation between nude mice TST and inflammation control mice at 
p<0.05 is denoted by *. Significant difference between nude mice TST and nude mice TST + 
Tempol is denoted by **. Significant difference between nude mice TST and B6 TST mice is 
denoted by ***. 
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Figure 26: Oxypurinic Cluster Analysis - Lung Carcinoma Experiment 
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Figure 26: Oxypurinic clusters that were detected from the Lung Carcinoma Experiment. 
Significant cluster accumulation between nude mice TST and inflammation control mice at 
p<0.05 is denoted by *. Significant difference between nude mice TST and nude mice TST + 
Tempol is denoted by **. Significant difference between nude mice TST and B6 TST mice is 
denoted by ***. 
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Figure 27: Cluster Analysis in Colon – MCP-1 KO  
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Figure 27: Cluster damage detected in colon tissue samples from the MCP-1 ko experiment for 
the three different enzymes that were utilized. The Y axis corresponds to the number of clusters 
(Gbp) and the X axis corresponds to the three different enzymes.  
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Figure 28: Cluster Analysis in Duodenum – MCP-1 KO 
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Figure 28: Cluster damage detected in duodenum tissue samples from the MCP-1 ko experiment 
for the three different enzymes that were utilized. The Y axis corresponds to the number of 
clusters (Gbp) and the X axis corresponds to the three different enzymes.  
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Figure 29: Cluster Analysis in Colon – B6 
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Figure 29: Cluster damage detected in colon tissue samples from the B6 experiment for the three 
different enzymes that were utilized. The Y axis corresponds to the number of clusters (Gbp) and 
the X axis corresponds to the three different enzymes.  
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Figure 30: Cluster Analysis in Duodenum – B6 
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Figure 30: Cluster damage detected in duodenum tissue samples from the B6 experiment for the 
three different enzymes that were utilized. The Y axis corresponds to the number of clusters 
(Gbp) and the X axis corresponds to the three different enzymes.  
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Figure 31: Abasic Cluster Analysis – MCP-1 KO vs. B6 
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Figure 31: Abasic clusters that were detected from the MCP-1 ko vs. B6 Experiment. Significant 
cluster accumulation between MCP-1 ko inflammation control and MCP-1 ko TST (Melanoma) 
at p<0.05 is denoted by „a‟. Significant difference between MCP-1 ko inflammation control and 
MCP-1 ko TST (Sarcoma) is denoted by *. Significant difference between MCP-1 ko TST 
(Sarcoma) and B6 TST (Sarcoma) is denoted by **. Significant difference between MCP-1 ko 
TST (Melanoma) and B6 TST (Melanoma) is denoted by ***. 
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Figure 32: Oxypyrimidinic Cluster Analysis – MCP-1 KO vs. B6 
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Figure 32: Oxypyrimidinic clusters that were detected from the MCP-1 ko vs. B6 Experiment. 
Significant cluster accumulation between MCP-1 ko inflammation control and MCP-1 ko TST 
(Melanoma) at p<0.05 is denoted by „a‟. Significant difference between MCP-1 ko inflammation 
control and MCP-1 ko TST (Sarcoma) is denoted by *. Significant difference between MCP-1 ko 
TST (Sarcoma) and B6 TST (Sarcoma) is denoted by **. Significant difference between MCP-1 
ko TST (Melanoma) and B6 TST (Melanoma) is denoted by ***. 
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Figure 33: Oxypurinic Cluster Analysis – MCP-1 KO vs. B6 
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Figure 33: Oxypurinic clusters that were detected from the MCP-1 ko vs. B6 Experiment. 
Significant cluster accumulation between MCP-1 ko inflammation control and MCP-1 ko TST 
(Melanoma) at p<0.05 is denoted by „a‟. Significant difference between MCP-1 ko inflammation 
control and MCP-1 ko TST (Sarcoma) is denoted by *. Significant difference between MCP-1 ko 
TST (Sarcoma) and B6 TST (Sarcoma) is denoted by **. Significant difference between MCP-1 
ko TST (Melanoma) and B6 TST (Melanoma) is denoted by ***. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
          
73 
 
 
Table 2: Lung Carcinoma Data 
LUNG CARCINOMA 
Tissue: OVARY       
Enzyme: 
 
APE ENDO  OGG 
  
 
Average Average Average 
  
 
Clusters (Gbp) Clusters (Gbp) Clusters (Gbp) 
NC Average 350.45 274.56 317.14 
  
Std. 
Dev 
86.61 76.89 83.74 
IC Average 349.01 573.95 408.78 
  
Std. 
Dev 
89.70 117.44 86.26 
C+Tempol Average 315.23 117.56 253.29 
  
Std. 
Dev 
87.93 46.96 76.49 
TST Average 1076.04 1277.37 1091.11 
  
Std. 
Dev 
243.60 113.08 193.26 
TST+Tempol Average 405.06 517.38 532.32 
  
Std. 
Dev 
120.91 114.23 140.68 
B6+TST Average 1149.35 942.30 767.57 
  
Std. 
Dev 
222.30 196.03 131.10 
T-Test (IC vs. TST) p-value 3.7E-06 2.8E-05 1.5E-05 
T-Test  (TST vs. TST+Tempol) p-value 9.4E-06 6.4E-07 3.6E-04 
T-Test (TST vs. B6+TST) p-value 3.0E-01 7.7E-01 1.5E-01 
 
Raw data obtained from lung carcinoma experiment. Averages are from three replicate sets.  
Student paired T-test was performed as paired analysis; p<0.05. 
 
 
 
 
 
          
74 
 
 
Tissue: SPLEEN       
Enzyme: 
 
APE ENDO  OGG 
  
 
Average Average Average 
  
 
Clusters 
(Gbp) 
Clusters 
(Gbp) 
Clusters 
(Gbp) 
NC Average 234.65 226.39 196.15 
  Std. Dev 79.67 75.39 59.77 
IC Average 381.28 497.81 541.61 
  Std. Dev 139.58 88.04 148.51 
C+Tempol Average 290.09 232.13 380.79 
  Std. Dev 98.25 86.82 96.79 
TST Average 965.57 1100.17 883.29 
  Std. Dev 213.95 88.72 180.10 
TST+Tempol Average 455.56 485.61 350.37 
  Std. Dev 139.14 143.09 89.16 
B6+TST Average 1204.95 917.33 1175.87 
  Std. Dev 212.65 218.20 181.67 
T-Test (IC vs. TST) p-value 9.4E-05 3.0E-04 3.9E-03 
T-Test  (TST vs. 
TST+Tempol) 
p-value 4.8E-04 2.4E-06 3.7E-05 
T-Test (TST vs. B6+TST) p-value 5.1E-02 1.1E-01 1.8E-01 
 
Raw data obtained from lung carcinoma experiment. Averages are from three replicate sets.  
Student paired T-test was performed as paired analysis; p<0.05. 
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Tissue: DUODENUM       
Enzyme: 
 
APE ENDO  OGG 
  
 
Average Average Average 
  
 
Clusters 
(Gbp) 
Clusters 
(Gbp) 
Clusters 
(Gbp) 
NC Average 297.17 245.44 396.16 
  Std. Dev 121.55 81.13 111.62 
IC Average 431.96 230.58 467.72 
  Std. Dev 139.07 69.61 108.89 
C+Tempol Average 248.41 253.21 376.01 
  Std. Dev 91.16 80.90 93.88 
TST Average 921.73 1331.18 1232.05 
  Std. Dev 243.00 195.25 204.02 
TST+Tempol Average 441.87 758.66 578.74 
  Std. Dev 130.13 167.80 159.73 
B6+TST Average 1235.08 1249.94 834.60 
  Std. Dev 273.89 208.47 127.99 
T-Test (IC vs. TST) p-value 4.5E-03 3.4E-06 1.7E-05 
T-Test  (TST vs. 
TST+Tempol) 
p-value 1.1E-02 2.0E-03 3.1E-05 
T-Test (TST vs. B6+TST) p-value 5.9E-02 6.8E-01 1.6E-01 
 
Raw data obtained from lung carcinoma experiment. Averages are from three replicate sets.  
Student paired T-test was performed as paired analysis; p<0.05. 
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Tissue: COLON       
Enzyme: 
 
APE ENDO  OGG 
  
 
Average Average Average 
  
 
Clusters 
(Gbp) 
Clusters 
(Gbp) 
Clusters 
(Gbp) 
NC Average 250.48 166.73 215.85 
  Std. Dev 84.72 55.11 60.63 
IC Average 434.33 371.17 533.77 
  Std. Dev 152.77 94.83 108.53 
C+Tempol Average 257.53 234.99 255.62 
  Std. Dev 77.27 88.70 85.19 
TST Average 1063.02 1161.22 981.95 
  Std. Dev 247.30 187.03 146.86 
TST+Tempol Average 429.90 574.85 478.96 
  Std. Dev 121.29 140.53 114.59 
B6+TST Average 1010.25 928.44 685.16 
  Std. Dev 213.95 193.88 103.63 
T-Test (IC vs. TST) p-value 2.9E-03 1.5E-03 3.0E-02 
T-Test  (TST vs. 
TST+Tempol) 
p-value 7.6E-04 1.7E-02 1.9E-02 
T-Test (TST vs. B6+TST) p-value 6.5E-01 2.9E-01 2.3E-01 
 
Raw data obtained from lung carcinoma experiment. Averages are from three replicate sets.  
Student paired T-test was performed as paired analysis; p<0.05. 
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Tissue: STOMACH       
Enzyme: 
 
APE ENDO  OGG 
  
 
Average Average Average 
  
 
Clusters 
(Gbp) 
Clusters 
(Gbp) 
Clusters 
(Gbp) 
NC Average 365.94 280.02 280.37 
  Std. Dev 83.76 99.89 90.37 
IC Average 402.04 385.10 458.40 
  Std. Dev 101.19 113.18 94.26 
C+Tempol Average 393.59 536.72 386.61 
  Std. Dev 117.54 159.58 116.51 
TST Average 1209.39 1483.56 1074.38 
  Std. Dev 271.09 200.14 180.59 
TST+Tempol Average 397.23 663.42 553.55 
  Std. Dev 98.38 113.16 99.99 
B6+TST Average 1516.00 1016.64 1376.48 
  Std. Dev 298.79 177.73 297.15 
T-Test (IC vs. TST) p-value 7.0E-04 6.7E-07 1.5E-04 
T-Test  (TST vs. 
TST+Tempol) 
p-value 1.5E-04 1.0E-06 1.4E-04 
T-Test (TST vs. B6+TST) p-value 1.4E-01 4.8E-01 7.7E-02 
 
Raw data obtained from lung carcinoma experiment. Averages are from three replicate sets.  
Student paired T-test was performed as paired analysis; p<0.05. 
 
 
 
 
 
 
 
 
 
          
78 
 
 
Tissue: RECTUM       
Enzyme: 
 
APE ENDO  OGG 
  
 
Average Average Average 
  
 
Clusters 
(Gbp) 
Clusters 
(Gbp) 
Clusters 
(Gbp) 
NC Average 159.96 161.18 284.67 
  Std. Dev 48.65 72.90 86.73 
IC Average 386.01 494.42 345.13 
  Std. Dev 83.70 103.43 97.48 
C+Tempol Average 180.63 271.67 140.43 
  Std. Dev 62.52 76.35 58.03 
TST Average 1075.70 951.26 946.52 
  Std. Dev 212.46 147.14 218.52 
TST+Tempol Average 372.99 582.61 391.18 
  Std. Dev 88.86 98.84 140.15 
B6+TST Average 1218.87 1109.07 965.91 
  Std. Dev 220.65 153.46 184.20 
T-Test (IC vs. TST) p-value 3.2E-05 1.0E-03 1.1E-05 
T-Test  (TST vs. 
TST+Tempol) 
p-value 1.9E-05 8.3E-03 5.4E-06 
T-Test (TST vs. B6+TST) p-value 3.0E-01 1.9E-01 9.4E-01 
 
Raw data obtained from lung carcinoma experiment. Averages are from three replicate sets.  
Student paired T-test was performed as paired analysis; p<0.05. 
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Tissue: SKIN DISTAL       
Enzyme: 
 
APE ENDO  OGG 
  
 
Average Average Average 
  
 
Clusters 
(Gbp) 
Clusters 
(Gbp) 
Clusters 
(Gbp) 
NC Average 438.82 436.41 319.50 
  Std. Dev 110.60 78.56 83.20 
IC Average 282.77 358.34 138.23 
  Std. Dev 159.29 122.53 99.94 
C+Tempol Average 384.10 414.92 565.26 
  Std. Dev 94.78 139.72 65.37 
TST Average 908.48 1209.63 1008.00 
  Std. Dev 77.53 168.49 161.13 
TST+Tempol Average 454.16 578.00 475.53 
  Std. Dev 98.54 121.38 99.05 
B6+TST Average 1386.87 818.21 723.55 
  Std. Dev 136.90 139.98 119.38 
T-Test (IC vs. TST) p-value 2.5E-03 5.7E-03 1.2E-03 
T-Test  (TST vs. 
TST+Tempol) 
p-value 3.4E-03 2.3E-04 3.9E-03 
T-Test (TST vs. B6+TST) p-value 3.0E-01 5.9E-02 9.0E-02 
 
Raw data obtained from lung carcinoma experiment. Averages are from three replicate sets.  
Student paired T-test was performed as paired analysis; p<0.05. 
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Tissue: 
SKIN 
CERVICAL 
      
Enzyme: 
 
APE ENDO  OGG 
  
 
Average Average Average 
  
 
Clusters 
(Gbp) 
Clusters 
(Gbp) 
Clusters 
(Gbp) 
NC Average 342.05 244.32 252.09 
  Std. Dev 116.33 83.97 62.88 
IC Average 335.70 300.54 318.43 
  Std. Dev 102.71 78.78 79.58 
C+Tempol Average 287.24 213.05 323.37 
  Std. Dev 62.30 94.11 92.18 
TST Average 1508.66 1428.47 1217.42 
  Std. Dev 276.92 234.03 116.74 
TST+Tempol Average 444.45 453.18 579.95 
  Std. Dev 113.06 118.17 122.46 
B6+TST Average 1312.92 1173.17 1211.05 
  Std. Dev 216.75 165.88 153.18 
T-Test (IC vs. TST) p-value 4.6E-05 1.4E-06 4.6E-08 
T-Test  (TST vs. 
TST+Tempol) 
p-value 5.8E-05 1.2E-05 3.4E-05 
T-Test (TST vs. B6+TST) p-value 2.1E-01 2.9E-01 6.5E-01 
 
Raw data obtained from lung carcinoma experiment. Averages are from three replicate sets.  
Student paired T-test was performed as paired analysis; p<0.05. 
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Tissue: TUMOR       
Enzyme: 
 
APE ENDO  OGG 
  
 
Average Average Average 
  
 
Clusters 
(Gbp) 
Clusters 
(Gbp) 
Clusters 
(Gbp) 
NC Average 438.82 436.41 319.50 
  Std. Dev 110.60 78.56 83.20 
IC Average 259.26 385.34 138.23 
  Std. Dev 62.73 122.53 44.70 
C+Tempol Average 384.10 414.92 565.26 
  Std. Dev 94.87 139.72 65.37 
TST Average 876.84 1203.88 1229.35 
  Std. Dev 170.73 154.40 186.35 
TST+Tempol Average 538.27 601.64 467.88 
  Std. Dev 112.45 129.23 99.70 
B6+TST Average 1224.26 1357.29 1793.98 
  Std. Dev 212.15 145.14 106.08 
T-Test (IC vs. TST) p-value 2.1E-03 1.6E-03 6.3E-04 
T-Test  (TST vs. 
TST+Tempol) 
p-value 7.4E-03 2.6E-03 1.5E-03 
T-Test (TST vs. B6+TST) p-value 1.9E-01 3.0E-01 6.6E-03 
 
Raw data obtained from lung carcinoma experiment. Averages are from three replicate sets.  
Student paired T-test was performed as paired analysis; p<0.05. 
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Table 3: MCP-1 / B6 Data 
MCP-1 KO 
Tissue: DUODENUM       
Enzyme: 
 
APE ENDO  OGG 
  
 
Average Average Average 
  
 
Clusters 
(Gbp) 
Clusters 
(Gbp) 
Clusters 
(Gbp) 
NC Average 193.40 154.08 172.09 
  Std. Dev 43.08 49.15 39.40 
IC Average 295.28 236.47 227.84 
  Std. Dev 77.24 38.86 59.34 
TST+Melanoma Average 416.83 494.73 260.24 
  Std. Dev 100.36 90.22 84.49 
TST+Sarcoma Average 534.43 544.77 300.05 
  Std. Dev 107.09 40.44 48.14 
T-Test (IC vs. TST+Melanoma) p-value 3.5E-01 1.8E-02 8.2E-01 
T-Test  (IC vs. TST+Sarcoma) p-value 1.1E-01 2.1E-02 2.5E-01 
T-Test (MCP-1 vs. B6 (Melanoma)) p-value 5.8E-02 8.2E-02 1.7E-02 
T-Test (MCP-1 vs. B6 (Sarcoma)) p-value 1.1E-02 6.2E-02 8.6E-02 
 
Raw data obtained from MCP-1 ko / B6 experiment. Averages are from three replicate sets.  
Student paired T-test was performed as paired analysis; p<0.05. 
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MCP-1 KO 
Tissue: COLON       
Enzyme: 
 
APE ENDO  OGG 
  
 
Average Average Average 
   
Clusters 
(Gbp) 
Clusters 
(Gbp) 
Clusters 
(Gbp) 
NC Average 257.30 176.60 196.61 
  Std. Dev 42.50 30.16 42.74 
IC Average 307.05 277.77 221.53 
  Std. Dev 88.19 49.34 22.04 
TST+Melanoma Average 422.96 517.77 193.70 
  Std. Dev 65.46 83.72 26.94 
TST+Sarcoma Average 420.33 455.52 207.05 
  Std. Dev 71.54 100.36 58.05 
T-Test (IC vs. TST+Melanoma) p-value 1.4E-01 7.1E-03 6.4E-01 
T-Test  (IC vs. TST+Sarcoma) p-value 1.8E-01 8.5E-02 4.3E-01 
T-Test (MCP-1 vs. B6 (Melanoma)) p-value 1.0E-01 3.5E-01 1.0E-02 
T-Test (MCP-1 vs. B6 (Sarcoma)) p-value 5.3E-02 4.9E-03 1.4E-02 
 
Raw data obtained from MCP-1 ko / B6 experiment. Averages are from three replicate sets.  
Student paired T-test was performed as paired analysis; p<0.05. 
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B6 
Tissue: DUODENUM       
Enzyme: 
 
APE ENDO  OGG 
  
 
Average Average Average 
  
 
Clusters (Gbp) Clusters (Gbp) Clusters (Gbp) 
NC Average 227.33 254.55 216.08 
  Std. Dev 50.83 36.88 66.89 
IC Average 279.99 262.00 217.82 
  Std. Dev 61.83 27.86 77.08 
TST+Melanoma Average 396.11 818.88 572.22 
  Std. Dev 79.60 91.02 100.05 
TST+Sarcoma Average 507.25 758.26 517.81 
  Std. Dev 111.70 125.89 138.12 
 
Raw data obtained from MCP-1 ko / B6 experiment. Averages are from three replicate sets.  
Student paired T-test was performed as paired analysis; p<0.05. 
 
B6 
Tissue: COLON       
Enzyme: 
 
APE ENDO  OGG 
  
 
Average Average Average 
  
 
Clusters (Gbp) Clusters (Gbp) Clusters (Gbp) 
NC Average 153.58 256.92 146.88 
  Std. Dev 57.90 40.05 44.87 
IC Average 166.03 233.68 177.24 
  Std. Dev 33.51 56.55 18.34 
TST+Melanoma Average 558.95 630.88 568.95 
  Std. Dev 96.38 73.95 95.62 
TST+Sarcoma Average 574.08 693.09 609.88 
  Std. Dev 102.37 113.11 34.90 
 
Raw data obtained from MCP-1 ko / B6 experiment. Averages are from three replicate sets.  
Student paired T-test was performed as paired analysis; p<0.05. 
 
  
CHAPTER 6: DISCUSSION 
Cancer continues to be one of the leading causes of death in the United States. Like many 
diseases, with earlier detection there is improved prognosis and more efficient treatment. In this 
study, three tumors were studied, lung carcinoma, melanoma and sarcoma, and subjected to 
various treatments. Analysis was performed to assess the amount of DNA damage, more 
specifically, the amount of OCDL formation. With different cohorts, we were able to elucidate 
sources of OCDL formation.  
For the lung carcinoma experiments, a comparison between the inflammation control and 
normal control mice tissues were made. There was an overall insignificant elevation in OCDL 
formation in the tissues for the mice that have been subjected to Freund‟s adjuvant. As 
mentioned above, a trend is noted, but there is no significant difference between the two cohorts. 
This suggests that basal inflammation increases OCDL levels, but is not the only biological 
mechanism that induces OCDL formation. 
A comparison was made between the inflammation control mice, the PBS control mice 
and the tumor bearing mice. In the tissues for all three enzymes, there is an increase in OCDL 
formation when the tumor is present. As opposed to my second hypothesis, regardless of the 
tissues being distal or proximal to the tumor, there is an increase in OCDL. This can be 
explained by the general increase in oxidative stress when the tumor is present. This effect is 
mediated by different cytokines, inflammation, ROS and RNS transmitted by the bystander/distal 
effect. The bystander/distal effect that was observed portrays the induction of DNA damage to 
tissues that are both proximal and distal to the site of tumor injection. 
The next comparison for the lung carcinoma experiment was with the addition of the 
antioxidant Tempol. The superoxide dismutase scavenges superoxide anions and neutralizes 
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them, thereby decreasing the level of intracellular oxidative stress. When comparing the mice 
plus the antioxidant Tempol to mice bearing lung carcinoma we see a significant decrease in 
OCDL formation. The significance is seen with the majority of the tissues for all three enzymes. 
From this, it can be concluded that a decrease in oxidative stress results into a decreased 
accumulation of OCDLs.  
A final comparison for the lung carcinoma experiment looked at nude mice bearing the 
tumor vs. B6 tumor bearing mice. The nude mice lack a thymus. Because of this, there is no T-
cell mediated response to tumors being present. Although there is no T-cell response, a cytokine 
analysis was performed on the nude mice. The presence of numerous cytokines was observed, 
but at lower levels when compared to B6 mice with the tumor where there was an increase ~3.5 
fold. When nude mice bearing a tumor were compared to B6 mice bearing a tumor, the OCDL 
formation showed no significant difference between the two cohorts. There was no trend that 
was established. This suggests that while the adaptive immunity may play a role in OCDL 
formation, a more profound role is seen with biological responses such as, cytokines, 
inflammation and innate immune, in the induction of OCDL formation.  
The rate of proliferation plays a significant role in the susceptibility of DNA damage and 
ROS productivity. Because of this, it was expected that the tissues with the highest rate of 
proliferation, such as the tissues from the GI tract, would exhibit the greatest amount of OCDL 
induction. This was not always verified. In several cases, such as with the addition of APE1, the 
ovary and lung exhibit an equivalent frequency of OCDL formation. 
In a cytokine analysis performed by Redon et al, monocyte chemoattractant protein-1 
(MCP-1) was observed to be up-regulated in the presence of tumors. MCP-1 functions as a signal 
for the recruitment of monocytes to a site of damage or injury. An increase in oxidative stress is 
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associated with the recruitment of monocytes and immunological response. Therefore, it is 
expected that with MCP-1 knocked out, there will be a decrease in overall oxidative stress and 
lower OCDL formation. 
MCP-1 functions as a stimulant for TGF-β. TGF-β is a protein in the body that assists 
with the regulation of cell proliferation. With MCP-1 being knocked out, it is expected that 
cellular proliferation will be reduced.   
A comparison was performed between inflammation control MCP-1 ko mice with MCP-
1 ko mice bearing tumors. Two tissues were tested, the duodenum and colon. Interestingly, for 
the colon, both abasic and oxypurine enzymes detected no statistical significant difference 
between the inflammation control and the melanoma bearing mice for MCP-1 ko in the mice. 
The mice bearing sarcoma and MCP-1 ko, all three enzymes did not detect a statistical difference 
when compared to MCP-1 ko inflammation control. The duodenum displayed similar results. 
Both abasic (APE1) and oxypurine (OGG1) enzymes detected no statistical difference between 
the melanoma bearing mice and the inflammation control for the MCP-1 ko mice. Only 
oxypurine enzyme detection displayed no statistical difference between sarcoma bearing mice 
and the inflammation control for the MCP-1 ko mice.  
A final comparison was composed assessing the differences between tumor bearing mice 
with MCP-1 ko and B6 tumor bearing mice. For the enzyme that detects oxypurines (OGG1), 
both the duodenum and colon show a significant decrease in OCDL formation for the tumor 
bearing mice with MCP-1 ko versus B6 tumor bearing mice. It is also seen for detection of 
oxypyrimidines, the colon displays a significant difference for the MCP-1 ko sarcoma bearing 
mice as compared to the B6 mice with the corresponding tumor. A significant difference is also 
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established for the duodenum tissue between the MCP-1 ko melanoma bearing mice when 
compared to the B6 mice bearing the corresponding tumor. 
The induction of oxidative damage was seen in tissues both proximal and distal to the 
tumor mass. This indicates the existence of one or more communication pathways being present 
between tissues. It has been demonstrated from previous studies that inflammation is a source of 
the bystander effect. Cytokines and intercellular communication have also been implemented as 
a source of this effect. This study shows for the first time that the manifestation of OCDLs in 
distant tissues is strongly mediated by the cytokine MCP-1. 
In a previous study performed by Redon et al, γ-H2AX analysis was performed to assess 
the DNA double stranded break damage in association with the presence of a tumor. 
Phosphorylated histone is utilized to detect the presence of DNA damage. It was seen that for the 
tissues that MCP-1 was knocked out, there was a decrease in double stranded breaks. 
Interestingly, this corresponds to the results that were obtained from the OCDL analysis that we 
performed. With the removal of the MCP-1 gene, there was a decrease in OCDL damage. This 
signifies MCP-1 as having a key role in the induction of DNA damage. 
With the findings from Redon et al and the findings from this experiment, there is a 
demonstration that the presence of tumors may induce an increase in the level of inflammation 
and damage that is sufficient to induce DNA damage in tissues both proximal and distal to the 
tumor. Furthermore, from this experiment, it can be seen with chronic inflammation, damage to 
DNA can arise, including an elevated risk for cancer formation. Induction and detection of 
OCDL formation along with further comprehension of the bystander/distal effect and the 
associated DNA damages will have great impacts in the clinical aspects of oncology prognosis 
and detection. It is hopeful to one day implement tissue biopsies for OCDL screening which in 
          
89 
 
 
turn will act as a biomarker for tumor presence and allow earlier prognosis. With earlier 
prognosis, treatments will be more effective ultimately leading to greater probability of 
remission.  
It is essential to expand this study and examine different tissues to truly grasp the effects 
of the bystander/distal phenomenon. Currently, two other carcinomas are be analyzed for OCDL 
formation along with broader tissue samples, such as the brain and kidneys. These studies will 
utilize B6 mice as their test cohorts along with the addition of the antioxidant Tempol.  
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